ID CWLC_BACSU Reviewed; 255 AA. AC Q06320; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 27-MAR-2024, entry version 141. DE RecName: Full=Sporulation-specific N-acetylmuramoyl-L-alanine amidase; DE EC=3.5.1.28; DE AltName: Full=Autolysin; DE AltName: Full=Cell wall hydrolase; GN Name=cwlC; OrderedLocusNames=BSU17410; OS Bacillus subtilis (strain 168). OC Bacteria; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus. OX NCBI_TaxID=224308; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION. RC STRAIN=168; RX PubMed=8407798; DOI=10.1128/jb.175.19.6260-6268.1993; RA Kuroda A., Asami Y., Sekiguchi J.; RT "Molecular cloning of a sporulation-specific cell wall hydrolase gene of RT Bacillus subtilis."; RL J. Bacteriol. 175:6260-6268(1993). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=168; RX PubMed=9384377; DOI=10.1038/36786; RA Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V., RA Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R., RA Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S., RA Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K., RA Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F., RA Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D., RA Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M., RA Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P., RA Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K., RA Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S., RA Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y., RA Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G., RA Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J., RA Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C., RA Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S., RA Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B., RA Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S., RA Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M., RA Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y., RA Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J., RA Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A., RA Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M., RA Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S., RA Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E., RA Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K., RA Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E., RA Yoshikawa H., Danchin A.; RT "The complete genome sequence of the Gram-positive bacterium Bacillus RT subtilis."; RL Nature 390:249-256(1997). RN [3] RP SEQUENCE REVISION TO 158. RX PubMed=19383706; DOI=10.1099/mic.0.027839-0; RA Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A., RA Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.; RT "From a consortium sequence to a unified sequence: the Bacillus subtilis RT 168 reference genome a decade later."; RL Microbiology 155:1758-1775(2009). RN [4] RP PROTEIN SEQUENCE OF 2-11, FUNCTION, CHARACTERIZATION, AND SUBCELLULAR RP LOCATION. RC STRAIN=168; RX PubMed=7601853; DOI=10.1128/jb.177.13.3855-3862.1995; RA Smith T.J., Foster S.J.; RT "Characterization of the involvement of two compensatory autolysins in RT mother cell lysis during sporulation of Bacillus subtilis 168."; RL J. Bacteriol. 177:3855-3862(1995). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 115-255. RC STRAIN=168; RA Scotti C., Valbuzzi A., Perego M., Galizzi A., Albertini A.M.; RL Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases. RN [6] RP FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION. RX PubMed=10945275; DOI=10.1271/bbb.64.1522; RA Shida T., Hattori H., Ise F., Sekiguchi J.; RT "Overexpression, purification, and characterization of Bacillus subtilis N- RT acetylmuramoyl-L-alanine amidase CwlC."; RL Biosci. Biotechnol. Biochem. 64:1522-1525(2000). RN [7] RP COFACTOR, AND MUTAGENESIS OF HIS-10; GLU-24; ASP-55; HIS-79; ASN-81 AND RP GLU-141. RX PubMed=11375403; DOI=10.1074/jbc.m103903200; RA Shida T., Hattori H., Ise F., Sekiguchi J.; RT "Mutational analysis of catalytic sites of the cell wall lytic N- RT acetylmuramoyl-L-alanine amidases CwlC and CwlV."; RL J. Biol. Chem. 276:28140-28146(2001). RN [8] RP STRUCTURE BY NMR OF 177-255, AND DOMAIN. RX PubMed=16042392; DOI=10.1021/bi050624n; RA Mishima M., Shida T., Yabuki K., Kato K., Sekiguchi J., Kojima C.; RT "Solution structure of the peptidoglycan binding domain of Bacillus RT subtilis cell wall lytic enzyme CwlC: characterization of the sporulation- RT related repeats by NMR."; RL Biochemistry 44:10153-10163(2005). CC -!- FUNCTION: Autolysins are involved in some important biological CC processes such as cell separation, cell-wall turnover, competence for CC genetic transformation, formation of the flagella - in particular of CC its basal body - and sporulation. CwlC is able to hydrolyze type A cell CC walls such as B.subtilis. Its main function is to lyze the mother cell CC wall peptidoglycan, playing a role during sporulation. CC {ECO:0000269|PubMed:10945275, ECO:0000269|PubMed:7601853}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Hydrolyzes the link between N-acetylmuramoyl residues and L- CC amino acid residues in certain cell-wall glycopeptides.; EC=3.5.1.28; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000305|PubMed:11375403}; CC -!- ACTIVITY REGULATION: Inhibited by EDTA. {ECO:0000269|PubMed:10945275}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 8.5-9.5. {ECO:0000269|PubMed:10945275}; CC Temperature dependence: CC Optimum temperature is 60 degrees Celsius. CC {ECO:0000269|PubMed:10945275}; CC -!- SUBCELLULAR LOCATION: Secreted, cell wall {ECO:0000269|PubMed:7601853}. CC Note=Is associated with the mother cell wall of sporulating cells. CC -!- INDUCTION: Induced at 6 to 7 hours after sporulation. CC {ECO:0000269|PubMed:8407798}. CC -!- DOMAIN: Contains an N-terminal catalytic domain and two C-terminal CC tandem repeat sequences that play an important role in peptidoglycan CC binding. {ECO:0000269|PubMed:16042392}. CC -!- SIMILARITY: Belongs to the N-acetylmuramoyl-L-alanine amidase 3 family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D14666; BAA03500.1; -; Genomic_DNA. DR EMBL; AL009126; CAB13625.2; -; Genomic_DNA. DR EMBL; Z68500; CAA92813.1; -; Genomic_DNA. DR PIR; A36935; A36935. DR RefSeq; NP_389623.2; NC_000964.3. DR RefSeq; WP_003244862.1; NZ_JNCM01000035.1. DR PDB; 1X60; NMR; -; A=177-255. DR PDBsum; 1X60; -. DR AlphaFoldDB; Q06320; -. DR BMRB; Q06320; -. DR SMR; Q06320; -. DR STRING; 224308.BSU17410; -. DR PaxDb; 224308-BSU17410; -. DR EnsemblBacteria; CAB13625; CAB13625; BSU_17410. DR GeneID; 940088; -. DR KEGG; bsu:BSU17410; -. DR PATRIC; fig|224308.179.peg.1887; -. DR eggNOG; COG0860; Bacteria. DR InParanoid; Q06320; -. DR OrthoDB; 9763643at2; -. DR PhylomeDB; Q06320; -. DR BioCyc; BSUB:BSU17410-MONOMER; -. DR EvolutionaryTrace; Q06320; -. DR Proteomes; UP000001570; Chromosome. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0030288; C:outer membrane-bounded periplasmic space; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IBA:GO_Central. DR GO; GO:0042834; F:peptidoglycan binding; IEA:InterPro. DR GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW. DR GO; GO:0030420; P:establishment of competence for transformation; IEA:UniProtKB-KW. DR GO; GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro. DR GO; GO:0030435; P:sporulation resulting in formation of a cellular spore; IEA:UniProtKB-KW. DR CDD; cd02696; MurNAc-LAA; 1. DR Gene3D; 3.30.70.1070; Sporulation related repeat; 1. DR Gene3D; 3.40.630.40; Zn-dependent exopeptidases; 1. DR InterPro; IPR002508; MurNAc-LAA_cat. DR InterPro; IPR007730; SPOR-like_dom. DR InterPro; IPR036680; SPOR-like_sf. DR PANTHER; PTHR30404:SF5; AUTOLYSIN PH-RELATED; 1. DR PANTHER; PTHR30404; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; 1. DR Pfam; PF01520; Amidase_3; 1. DR Pfam; PF05036; SPOR; 1. DR SMART; SM00646; Ami_3; 1. DR SUPFAM; SSF110997; Sporulation related repeat; 1. DR SUPFAM; SSF53187; Zn-dependent exopeptidases; 1. DR PROSITE; PS51724; SPOR; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell wall; Cell wall biogenesis/degradation; Competence; KW Direct protein sequencing; Hydrolase; Metal-binding; Reference proteome; KW Repeat; Secreted; Sporulation; Zinc. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:7601853" FT CHAIN 2..255 FT /note="Sporulation-specific N-acetylmuramoyl-L-alanine FT amidase" FT /id="PRO_0000164418" FT DOMAIN 4..172 FT /note="MurNAc-LAA" FT /evidence="ECO:0000255" FT DOMAIN 180..254 FT /note="SPOR" FT REPEAT 184..219 FT /note="1" FT REPEAT 220..255 FT /note="2" FT REGION 184..255 FT /note="2 X 35 AA approximate tandem repeats" FT ACT_SITE 141 FT /evidence="ECO:0000255" FT BINDING 10 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255" FT BINDING 24 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255" FT BINDING 79 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255" FT MUTAGEN 10 FT /note="H->Q: 23% of wild-type activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 24 FT /note="E->A,Q,S: Loss of activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 55 FT /note="D->V: Loss of activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 79 FT /note="H->L: Loss of activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 79 FT /note="H->Q: 15% of wild-type activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 81 FT /note="N->I: Loss of activity." FT /evidence="ECO:0000269|PubMed:11375403" FT MUTAGEN 141 FT /note="E->Q,V: Loss of activity." FT /evidence="ECO:0000269|PubMed:11375403" FT CONFLICT 158 FT /note="S -> T (in Ref. 5; CAA92813)" FT /evidence="ECO:0000305" FT STRAND 185..194 FT /evidence="ECO:0007829|PDB:1X60" FT HELIX 196..209 FT /evidence="ECO:0007829|PDB:1X60" FT STRAND 213..218 FT /evidence="ECO:0007829|PDB:1X60" FT STRAND 221..231 FT /evidence="ECO:0007829|PDB:1X60" FT HELIX 232..245 FT /evidence="ECO:0007829|PDB:1X60" FT STRAND 250..254 FT /evidence="ECO:0007829|PDB:1X60" SQ SEQUENCE 255 AA; 27146 MW; 30C950116784FBC1 CRC64; MVKIFIDPGH GGSDPGATGN GLQEKTLTLQ IALALRTILT NEYEGVSLLL SRTSDQYVSL NDRTNAANNW GADFFLSIHV NSGGGTGFES YIYPDVGAPT TTYQSTIHSE VIQAVDFADR GKKTANFHVL RESAMPALLT ENGFIDTVSD ANKLKTSSFI QSLARGHANG LEQAFNLKKT SSSGLYKVQI GAFKVKANAD SLASNAEAKG FDSIVLLKDG LYKVQIGAFS SKDNADTLAA RAKNAGFDAI VILES //